1Suppliers
0Customers
1Debt Items
20Related Chains
Pharvaris N.V. Suppliers
| Ticker | Name | Confidence | Evidence |
|---|
| CDMOS |
CDMOS |
92%
|
We currently rely on a small number of CDMOs for the production of certain of our product candidates |
Pharvaris N.V. Customers
No clients on recordNo downstream customers found in our database for Pharvaris N.V..
Pharvaris N.V. Debt Obligations
| Instrument | Description | Confidence | Evidence |
|---|
| PHVS-DEBT |
Debt stack $859,875 |
90%
|
Market cache reports total debt of $859,875. |
Pharvaris N.V. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Pharvaris N.V..
Pharvaris N.V. Ownership
| Holder | Name | Confidence | Evidence |
|---|
| PHVS-OWNER-GENERAL-ATLANTIC-L-P |
GENERAL ATLANTIC, L.P. |
90%
|
13F overlay lists GENERAL ATLANTIC, L.P. as top holder; 111 tracked holders. |
Pharvaris N.V. Extended Supply Chain Network
| Ticker | Name | Chain Index | Hops | Relationship Types |
|---|
| DBVTF |
DBV TECHNOLOGIES |
100.00 |
2 |
|
| BNTC |
Benitec Biopharma Inc. |
100.00 |
2 |
|
| WHWK |
Whitehawk Therapeutics, Inc. |
100.00 |
2 |
|
| BLRX |
BioLineRx Ltd. |
100.00 |
2 |
|
| ALXO |
ALX Oncology Holdings Inc. |
100.00 |
2 |
|
| ATOS |
Atossa Therapeutics, Inc. |
100.00 |
2 |
|
| BNBX |
BNB Plus Corp. |
100.00 |
2 |
|
| CYTOF |
Altamira Therapeutics Ltd. |
100.00 |
2 |
|
| CTMX |
CytomX Therapeutics, Inc. |
100.00 |
2 |
|
| CYTK |
Cytokinetics, Incorporated |
100.00 |
2 |
|
| CBIO |
Crescent Biopharma, Inc. |
100.00 |
2 |
|
| ANL |
Adlai Nortye Ltd. |
100.00 |
2 |
|
| ANRO |
Alto Neuroscience, Inc. |
100.00 |
2 |
|
| EDIT |
Editas Medicine, Inc. |
100.00 |
2 |
|
| CCEP |
Coca-Cola Europacific Partners PLC |
100.00 |
2 |
|
| DSGN |
Design Therapeutics, Inc. |
100.00 |
2 |
|
| PSNL |
Personalis, Inc. |
100.00 |
2 |
|
| AZN |
AstraZeneca PLC |
100.00 |
2 |
|
| BIOA |
BioAge Labs, Inc. |
100.00 |
2 |
|
| REGN |
Regeneron Pharmaceuticals, Inc. |
100.00 |
2 |
|
